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Abstract
Background
Onchocerciasis control in Coˆte d’Ivoire started with aerial insecticide spraying in 1974 and
continued with community directed treatment with ivermectin (CDTi) from 1992 to the pres-
ent. Onchocerciasis and lymphatic filariasis (LF) are co-endemic in 46 of the 81 health dis-
tricts in the country. Fourteen and 12 districts are endemic for only LF or onchocerciasis,
respectively. This paper aims to review the impact of past interventions on onchocerciasis in
Coˆte d’Ivoire between 1975 and 2013, and review plans for disease elimination.
Methods
We reviewed microfilaria (MF, skin snip) prevalence and community microfilarial load
(CMFL) data from published reports from 53 health districts during two major epidemiologi-
cal assessment periods. Data from 1975 through 1991 provided information on the impact
of vector control, and data from 1992 through 2016 provided information on the impact of
CDTi.
Results
Weekly aerial insecticide spraying in 8 endemic districts between 1975 and 1991 reduced
the overall MF prevalence by 68.1% from 43.5% to 13.9%. The CMFL also decreased in 7
out of 8 surveyed communities by 95.2% from 9.24 MF/snip to 0.44 MF/snip. Ivermectin dis-
tribution started in 1992. The coverage targets for control (65% of the total population) was
reached in most endemic districts, and some areas achieved 80% coverage. Two sets of
surveys were conducted to assess the impact of CDTi. Results from the first repeat surveys
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showed a significant decrease in overall MF prevalence (by 75.7%, from 41.6% to 10.1%).
The second follow-up evaluation showed further improvement in most endemic districts and
also documented major reductions in CMFL compared to baseline.
Conclusions
Extensive data collected over many years document the very significant impact of interven-
tions conducted by the National Onchocerciasis and other Eyes Diseases Control Pro-
gramme during challenging times with periods of civil unrest. The Health Ministry has now
integrated efforts to control neglected tropical diseases and adopted the goal of onchocerci-
asis elimination.
Author summary
Onchocerciasis has recently been targeted for elimination in Coˆte d’Ivoire. With support
of international donors the country’s integrated Neglected Tropical Diseases (NTD) pro-
gram has recently achieved 100% geographical coverage for mass drug administration in
districts endemic for lymphatic filariasis and onchocerciasis. From 1975 to 1991 oncho-
cerciasis control in Coˆte d’Ivoire was based on weekly aerial spraying of insecticide on tar-
geted rivers. From 1992 to present, community directed treatment with ivermectin by
community drug distributors was implemented in most endemic areas. Although the
country experienced periods of civil disturbance that interrupted distribution of ivermec-
tin for several years, significant progress was made during this time toward onchocerciasis
elimination. There have been significant reductions in both microfilarial prevalences and
community microfilarial loads in sentinel villages that had implementation of vector con-
trol and/or mass drug administration coverage rates of at least 65%. Although onchocerci-
asis persists in some areas, changes in management of the programme in 2015 together
with improved political stability and increased support from key donors may lead to its
elimination over the next 10 years.
Introduction
Onchocerciasis (also known as “river blindness”) is a serious public health problem that has
hindered socioeconomic development in endemic areas in sub-Saharan Africa [1]. The disease
is caused by the filarial parasite Onchocerca volvulus that is transmitted by Simulium black
flies. This infection causes excess mortality [2] and significant morbidity that can include
severe dermatitis with itching, skin depigmentation, subcutaneous nodules where adult para-
sites are located, and visual impairment [3].
The initial efforts of the Onchocerciasis Control Programme in West Africa (OCP) focused
on vector control through aerial application of larvicides in black fly breeding sites from 1974
to 1992 in 11 West African countries [4]. Vector control had a positive impact on controlling
onchocerciasis in many savannah areas, but it was difficult to implement in densely forested
areas. Since 1987 the recommended control strategy for onchocerciasis in Africa has been
annual or semi-annual mass treatment with ivermectin, which kills the microfilarial progeny
that cause skin disease and blindness. From 2002, when OCP was taken over by the African
Programme for Onchocerciasis Control (APOC) through 2015 when APOC closed, more than
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PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006897 October 23, 2018 2 / 16
design, data collection and analysis, the decision to
publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
1 billion ivermectin treatments were administered, and more than 2 million cases of blindness
were prevented [5]. Successes against onchocerciasis in sub-Saharan Africa and Latin America
can be mainly attributed to the extensive and sustained mass treatment programs [5]. Since
2016, efforts to control and eliminate onchocerciasis in Africa have been managed by the
Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN).
Coˆte d’Ivoire is highly endemic for a number of Neglected Tropical Diseases (NTD) includ-
ing onchocerciasis and lymphatic filariasis (LF). The two diseases are co-endemic in 46 of the
country’s 81 health districts. Fourteen and 12 districts are endemic for only LF or onchocercia-
sis, respectively, and 9 districts are not endemic for either disease. The total population of the
country was in 2015 25,236,292, and the estimated population living within 5 km from the riv-
ers including villages with less than 2,000 inhabitants that are considered to be at especially
high risk for onchocerciasis was 2,867,122. Coˆte d’Ivoire experienced several periods of civil
disturbance in recent years that peaked in 2002 and in 2011. This has had negative impacts on
the economy and on the public health infrastructure [6], and many international research and
aid organisations left the country during this time. Political stability has improved, but it could
take a decade or more to rebuild the public health and research infrastructures.
Control of onchocerciasis started with the beginning of the OCP in 1974, but it was initially
limited to the northern (savannah) region of the country. Vector control activities reached the
central region from 1986 to 1991 [6]. In 1992, most countries supported by OCP including
Coˆte d’Ivoire started mass distribution of ivermectin through community directed treatment
(CDTi) with a single annual oral dose of 150 μg/kg body weight. The closure of OCP in 2002
coincided with the start of the civil war in Coˆte d’Ivoire. This made it impossible for the
National Onchocerciasis Control Programme to sustain onchocerciasis control activities
between 2002 and 2007, especially in endemic districts of the northern, central and western
regions that were occupied by rebel forces. This was a serious problem because onchocerciasis
was the second most common cause of blindness in the country after cataract [8]. Fortunately,
support from APOC together with a calmer political environment helped to restart CDTi in
the troubled areas in 2008.
Coˆte d’Ivoire is now taking steps to eliminate onchocerciasis. The country’s integrated
NTD program has recently achieved 100% geographical coverage for mass drug administra-
tion (MDA) in all districts endemic for LF and onchocerciasis (only 8 districts are endemic for
onchocerciasis only). The purpose of this paper is to review published data on the impact of
vector control and CDTi activities that started in endemic districts in 1975 and in 1992, respec-
tively, and to summarize the most recent data on the distribution and prevalence of onchocer-
ciasis in the country. We conducted this exercise to support the onchocerciasis eliminate
program by identifying key gaps in the data and by highlighting potential problem areas that
may require special attention.
Materials and methods
Study areas
The country is divided into four geographical zones: forest, pre-forest, savannah and mountain
that each have specific ecological features and climates. Historically, blinding onchocerciasis
occurred mainly in the savannah zones in the northern part of the country, and early interven-
tion activities were focussed on these areas. From 1975 to 1991, aerial application of insecticide
(Temephos) was carried out in rivers and streams close to villages eight districts located in the
Comoe´ River basin (Abengourou, Bouake´, Bouna, Boundiali, Daoukro, Korhogo, Mankono
and Se´gue´la). Intervention focussed on CDTI from 1992 to 2013, although ivermectin distribu-
tion was interrupted in most districts due to the civil war in 2003, 2004 and 2007. More
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recently, CDTi was extended beyond villages in 53 districts located along basins of the Sassan-
dra, Comoe´, N’zi-Bandama, Marahoue´ and Black Volta rivers. MDA programmes for LF
using ivermectin combined with albendazole and CDTi for onchocerciasis have been inte-
grated since 2015.
Implementation of CDTi
According to the National Onchocerciasis Control Programme, ivermectin mass drug admin-
istration (MDA) started in Coˆte d’Ivoire in 1992 in basins of rivers listed above (Sassandra,
N’zi-Bandama, Comoe´, Marahoue´ and Black Volta) and in 1998 ivermectin distribution was
changed to compile to APOC’s CDTi approach. From 1992 to 2002, some 1,500 villages
received at least one round of ivermectin. Villages in areas drained by the Sassandra, Comoe´,
and N’Zi-Bandama rivers were treated twice per year in 1995 and in 1996 [7]. Community
health workers (CHWs) became Community Drug Distributors (CDDs) in 1998 as part of the
APOC program [5]. Each year, before each CDTi, CDDs performed a pre-treatment census
and updated the community register to show those who had moved away, those who had
joined the community, and the newly born. CDDs were trained to use dosing poles to deter-
mine the number of tablets of ivermectin to be administered. District health staff and CDDs
from targeted villages were trained to conduct CDTi and report any adverse events following
treatment to senior district health staff. CDTi was conducted once per year from 1992 in tar-
geted villages listed in 53 districts (S1 Table). The program aimed to cover at least 65% of resi-
dents in endemic villages (the coverage goal), but some areas achieved 80% coverage. CDTi
implementation was entirely suspended in 13 out of 53 districts located in regions occupied by
rebel forces in 2003–4 and in 2007. CDTi was also incomplete in the other 40 districts during
this period. MDA was only provided in villages along rivers with fewer than 2,000 inhabitants.
Ethical clearance
Protocols for epidemiological surveys were reviewed and approved by OCP and APOC scien-
tific committees and included approval by the institutional review board of the Ministry of
Health in Coˆte d’Ivoire. During the first surveys, APOC staff worked together with local staff
to make sure that epidemiological surveys were implemented according to validated standard
operating procedures [9]. However, all epidemiological surveys were carried out by staff from
onchocerciasis control programme of the Ministry of Health.
All participants aged 5 years or above in each site were eligible for inclusion without dis-
crimination on gender, social status, religion or ethnicity. Before being skin snipped, a staff
member explained to each participant the purpose and procedures including potential risks
and benefits of the study. Participants were allowed to ask any question they may have in rela-
tion to the survey. From 2009, all protocols of epidemiological surveys were reviewed and
approved by the National Ethics Committee for Research in Coˆte d’Ivoire.
In brief, oral/ verbal informed consent was obtained from individuals aged 18 years and
above. For minors (aged <18 years), written informed consent was obtained from parents or
legal guardians, while minors provided oral assent. Due to high illiteracy rate, in some house-
holds, oral rather than written informed consent was obtained. The National ethics committee
explicitly approved these consent procedures. With the help of the community health workers,
participants were informed about the purpose and procedures of the study, including potential
risks and benefits in local languages. After explaining the study to the communities and
addressing all their questions and comments, the chiefs of all selected villages were asked to
put his finger print at the bottom of the participant information sheet. The data were analysed
Current status of onchocerciasis after 40 years of intervention
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and reported without any directly identifiable information, to maintain anonymity of
participants.
Epidemiological evaluations
Selection of sentinel sites. Depending of their accessibility and the size of the district, 2 to
4 villages were surveyed per district during all epidemiological evaluations. Village selection
was based on their proximity to the main river (� 5 kms) and population (� 2,000). Informa-
tion from local health staff and prior data on onchocerciasis endemicity were also used in the
selection process [10]. In most cases the same sentinel villages were repeatedly surveyed. Thus,
districts were not systematically or randomly sampled.
Parasitological examination. Parasitological surveys were carried out together with clini-
cal examinations between 1975 and 2016 in 42 districts starting with a baseline survey and fol-
lowed by three follow-up surveys. An additional 11 districts were surveyed for the first time
after 2014. Skin snip surveys were conducted in sentinel villages prior to MDA. Briefly, the
parasitological examination involved taking two skin snips from each posterior iliac crest
using a 2 mm corneoscleral punch (Holth-type). Punches were only used for one person and
then sterilized by immersion in ethanol, rinsed in distilled water, and then autoclaved under
pressure for 15 minutes.
After collection, the skin snips were placed separately into microtitration plate wells with
sterile normal saline solution, and these were viewed by microscopy (40X). The microfilarial
load was defined as the arithmetic mean of the MF numbers in two snips from the iliac crests
[11]. The first reading was performed after 30 minutes of incubation by experienced parasitol-
ogists and a second reading was performed after 24 hr incubation by a senior member of staff
to confirm or correct the first reading. Snips were not weighed. For quality control, all positive
slides and 10% of the negative slides were re-examined by experienced and qualified indepen-
dent scientists working with the National Onchocerciasis Control Programme in Coˆte
d’Ivoire.
CDTi procedures. Ivermectin (150 μg/kg body weight) was provided in all endemic com-
munities to all residents� 5 years of age apart from pregnant women and people with acute ill-
nesses. All communities located within 5 km from a river and with a population of� 2000
were eligible for CDTi. Larger communities were not treated. From 2003 to 2015 when APOC
provided technical support, all epidemiological surveys were carried out 10–12 months after
the last CDTi round. Additionally, at the end of each epidemiological survey in sentinel vil-
lages, all participants reported as positives and not treated during implementation of annual
CDTi were treated.
Sources of data
Authors reviewed records of the National Onchocerciasis Control Programme and compila-
tion of interviews conducted with current and past programme directors and staff of oncho-
cerciasis control programme.
Statistical analysis
Results were entered Microsoft Excel spreadsheet and statistical analyses were performed
using STATA version 14 (Stata Corporation; College Station, TX, USA). Prevalence and inten-
sity of infection or community MF load (CMFL) were calculated for all districts and compared
with baseline data. MF prevalence was calculated as the percentage of participants with MF in
skin snips. 95% confidence intervals (CIs) for prevalence were calculated using the Clopper-
Pearson exact method. The Chi-squared test was used to compare the differences in
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prevalence. The National Onchocerciasis Control Programme provided database with CMFL
calculation for each site per district, thus for each district median and range was calculated and
pairwise comparisons of results by district were performed by the Mann-Whitney test. The
authors used geographical information system software ArcGIS version 10.2 (ESRI Inc., Red-
lands, USA) to draw original maps of onchocerciasis MF prevalence at the district level (S1
Table). Onchocerciasis endemicity was stratified according to World Health Organization
guidelines into three levels depending on MF rates in communities: hyperendemic
(MF> 60%), hypoendemic (MF <35%) and mesoendemic onchocerciasis (MF between 35%
and 60%) [12].
Results
History of interventions conducted for onchocerciasis control
Onchocerciasis control using larvicides. During the OCP period (1974–1991), the rivers
in all endemic districts were sprayed once a week with larvicidal insecticide. During the APOC
period (2003–2015 with an interruption between 2004 and 2007), only hyper and meso-
endemic districts were treated by CDTi according to WHO recommendations [13]; CDTi was
not provided in hypo-endemic areas.
Use of larvicides started in 1975 in villages in 8 districts (Abengourou, Bouake´, Boundiali,
Daoukro, Katiola, Korhogo, Mankono and Se´gue´la) located along the Feredougouba river, a
tributary of Sassandra river [14]. This intervention included weekly aerial application of insec-
ticide (temephos) to the riverine breeding sites of the vector Simulium damnosum s.l. The
spraying program ended in 1991.
Reduction in MF prevalence and density after aerial application of insecticide. Fig 1A
and 1B presents onchocerciasis MF prevalence and density data by district at baseline and
reductions observed after weekly aerial insecticide spraying in 8 endemic districts, in Coˆte
d’Ivoire (1975–1991). This intervention resulted in significant reductions in MF prevalence
relative to baseline proportions in 7 out of 8 surveyed districts (P< 0.001). Overall MF preva-
lence dropped significantly [from 43.5 (95%CI 42.6–44.3)% to 13.9 (95%CI 12.8–15.1)%, P<
0.001]. The overall reduction of MF prevalence was 68.1%. CMFL decreased significantly in 7
out of 8 surveyed communities by 95.2% from 9.24 (range 0.05–44.8) MF/snip to 0.44 (range
0–4.64) MF/snip (U = 5.290; P<0.001). Surprisingly, in Daoukro district, there was a signifi-
cant increase in MF prevalence [from 21.4 (95%CI 18.6–24.3) to 46.7% (95%CI 42.0–51.2)%,
P<0.001] and an increase in CMFL [from 1.69 (range 0.23–3.14) MF/snip to 4.64 MF/ snip;
P = 0.221]. In the endemic districts surveyed, reductions in MF prevalence ranged from 38 to
95%, and CMFL reductions ranged from 40 to 99%.
CDTi coverage from 1992 to 2015
Larger villages were not treated with ivermectin between 1992 and 2014. Annual MDA with
ivermectin plus albendazole was initiated in districts co-endemic for onchocerciasis and LF in
2015 while districts endemic for onchocerciasis only were treated from 1992 to 2014.
Ivermectin distribution was performed in limited areas in 1992. From 1995 to 1998,
350,000 to 370,000 persons were treated per year. These populations were located along the
basin of Sassandra, Black Volta, Comoe´, N’Zi-Bandama and Bou-Bandama rivers. From 2003
to 2004, and in 2007 due to the instability and the civil war, MDA was not implemented in 13
out of 28 districts belonging to the Western, Northern and Central regions (Man, Korhogo,
Bouake´, Odie´nne´, Bouna) occupied by rebels. CDTi re-started in 2005. From 2008 to 2014
CDTi was carried out continuously in only 11 districts (Abidjan, Aboisso, Dabou, Gagnoa,
Grand Lahou, Sakassou, Sikensi, Sinfra, Tabou, Touleupleu, Zouan-Hounien) and incomplete
Current status of onchocerciasis after 40 years of intervention
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in 15 districts. S2 Table presents the number of people eligible and treated for onchocerciasis
from 2008 to 2015 in endemic districts. Therapeutic coverage was at least 65% between 2008
and 2013 with the following exceptions: Biankouma and Mankono districts in 2008, Divo,
Guiglo and Zouan-Hounien districts in 2009, Mankono, Korhogo, Bangolo and Akoupe´ dis-
tricts in 2010, and Boundiali districts in 2011 (Fig 2). The 65% coverage target was not
achieved in Gueyo, Sassandra, Soubre´ and Tabou districts in 2014. From 2012 to 2016, the
therapeutic coverage for elimination (80%) [10] was achieved in most endemic districts. It is
important to emphasize that ivermectin distribution implemented before 2015 did not cover
Fig 1. Results of 1975–1991 onchocerciasis skin snip microfilaria prevalence and density by district in Coˆte d’Ivoire. (A) MF prevalence, (B) MF density.
https://doi.org/10.1371/journal.pntd.0006897.g001
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larger villages with more than 2,000 inhabitants as recommended in CDTi strategy. However,
since 2015 CDTi has been integrated and extended to entire districts co-endemic for LF and
onchocerciasis meaning that ivermectin and albendazole are now given to all eligible people in
co-endemic districts for LF and onchocerciasis (and not only in villages with less than 2,000
inhabitants).
In 2015 to 2016, 100% geographical coverage was reached for all districts co-endemic for
LF and onchocerciasis, and in districts endemic only for onchocerciasis, and 80% therapeutic
coverage was achieved in most districts during this period.
Baseline onchocerciasis MF prevalence prior to all interventions
Fig 3 summarise the results of the baseline of onchocerciasis MF prevalence, in 47 endemic
districts from 1975 to 2016.
Baseline MF prevalences between 1975 and 1991 from 8 districts (based on skin snip data
from 26,507 people varied from 3.9% (95% CI 2.0–6.7) to 85.3% (95%CI 79.4–89.6). From
2008 to 2014, baseline survey was carried out in 11 additional districts located in the forest
region. The overall MF prevalence for these 11 districts was 7.0% (95%CI 6.4–7.8) and the
CMFL was 0.08 (range 0–4.01) MF/ snip (S3 Table). No epidemiological evaluation was carried
out in these 11 districts. In total, 47 districts were surveyed from 1975 to 2016 (6 out of 53 dis-
tricts missing baseline were excluded from analysis). Based on skin MF prevalence data pre-
sented in Fig 3A, three of 36 districts in the (forest region) were classified as meso-endemic
(Ale´pe´, Danane´, Soubre´), and 33 districts were hypo-endemic. In the savannah area, one of
seven districts was hyperendemic, five were meso-endemic, and one was hypo-endemic. In the
forest area, baseline surveys were carried out in 16 districts. Six were found to be hyperen-
demic, 6 were meso-endemic, and 4 were hypo-endemic. In the pre-forest area (transition
from forest to savannah) in central and Eastern Coˆte d’Ivoire, 3 of 13 districts were meso-
endemic and 10 were hypo-endemic. The overall MF prevalence (means of MF prevalence
Fig 2. Proportion (%) of eligible people treated against onchocerciasis (therapeutic coverage) in endemic districts from 2008 to 2015.
https://doi.org/10.1371/journal.pntd.0006897.g002
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rates recorded in districts belonging to different ecological zones) recorded in savannah, forest
and pre-forest regions was 47.4% (95% CI 46.6–48.1), 46.8 (95% CI 46.1–47.5)% and 31.3
(95% CI 30.6–31.9)%, respectively. Onchocerciasis MF prevalence was significantly lower in
pre-forest regions compared to savannah (p< 0.001) and forest regions (p< 0.001).
Baseline onchocercal MF density before all interventions
S2 Table presents baseline median MF densities for 36 districts. The median value for these
districts was 6.69 (range 0–123.3) MF/snip. The overall density of MF was 0.08 (range 0–4.01)
MF/snip for 11 districts in forest region that had baseline surveys between 2008 and 2014.
CMFL levels in districts located in forest, savannah and pre-forest regions were 11.52 (range
0.02–118.05) MF/snip, 8.44 (range 0–123.3) MF/snip and 2.27 (0.01–81.48) MF/snip, respec-
tively. MF density was significantly lower in pre-forest regions compared to savannah
(p = 0.019) and forest regions (p = 0.003).
Reductions in MF prevalence and density after ivermectin distribution
Fig 4A and 4B presents data on onchocerciasis MF prevalence and density by district at base-
line and after the second and third epidemiological evaluations were conducted after periods
of annual CDTi. The first survey (1992–2002) and the second survey (2007–2016) covered 36
endemic districts. Results from the first repeat survey showed that MF prevalence decreased in
35 out of 36 surveyed districts following ivermectin distribution. The overall MF prevalence
Fig 3. Baseline onchocerciasis MF prevalence of onchocerciasis assessed by microfilaria detection in skin snips. (A) 1975–1991 Baseline evaluation prior to
aerial spraying; (B) 1992–2016 baseline evaluations of MF prevalence in additional districts during CDTi.
https://doi.org/10.1371/journal.pntd.0006897.g003
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dropped significantly by 75.7% [from 41.6% (95%CI 41.2–42.0) to 10.1% (95%CI 9.9–10.3),
P< 0.001]. Percent reductions in MF prevalence by district varied from 15.6 to 99.4% (S2
Table). Bocanda district was an exception where the MF prevalence increased from 5.3% (95%
CI 3.5–7.7) to 9.6% (95% CI 4.7–17.0).
The second follow up epidemiological evaluation also documented reductions in MF preva-
lence in most districts. The overall MF prevalence dropped by 86.5% from baseline [from
41.6% (95%CI 41.2–42.0) to 5.6% (95%CI 5.4–5.9), P< 0.001)]; percent reductions varied from
80 to 100% in 23 districts and between 70–80% in 4 districts. There was a significant decrease
in overall MF prevalence between the first and second follow up surveys [from 10.1% (95%CI
9.9–10.3) to 5.6% (95%CI 5.4–5.9), P< 0.001].
Based on comparisons of baseline and first follow-up surveys, the reduction in MF preva-
lence after weekly aerial insecticide spraying (16 years of interventions) was significantly lower
than after ivermectin distribution (15 rounds of CDTi) (68.1% vs 75.7% reduction) (P<
0.001).
The first and second follow up surveys also documented dramatic reductions in CMFL
compared to baseline [from 6.69 (range 0–123.3) MF/snip to 0.05 (range 0–17.62) MF/snip
Fig 4. Results of 1975–2016 onchocerciasis skin snip microfilaria prevalence and density by district in Coˆte d’Ivoire. (A) MF prevalence, (B) MF density.
https://doi.org/10.1371/journal.pntd.0006897.g004
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after weekly aerial larvicide spraying and from 6.69 (range 0–123.3) MF/snip to 0.01 (0–10.71)
MF/ snip after CDTi implementation, respectively]. CMFL values decreased in all districts
except in Bocanda where a slight increase was recorded (from 0.17 MF/snip to 0.3 MF/snip).
CMFL values were 99.3% and 99.8% lower than baseline at the time of the first and second fol-
low up surveys, respectively. These reductions were superior to those achieved by aerial spray-
ing of insecticides in the 1970s. Reductions in CMFL from baseline by district in the first and
second follow up surveys ranged from 70–100% and 81–100%, respectively.
Impact of civil war and interruption of CDTi on prevalence and density of
onchocerciasis MF (2005–2006; 2008–2015)
Although high coverage rates were reported from most endemic districts in most years, results
presented in Fig 2 and S3 Table show that many districts missed one or more rounds of MDA
between 2005 and 2015. MDA was continuously implemented in only 11 districts after 2007.
For example, Lakota district received MDA from 2009 to 2011 but missed 5 rounds (2008,
2012, 2013, 2014 and 2015 rounds). Some districts were assessed during the first follow up sur-
vey program but not in the second, and vice versa. This makes comparisons over time difficult
in some cases.
Due to the civil war and instability, CDTi was not implemented in 2003, 2004, and 2007.
Also, as mentioned above, CDTi was only intermittently provided in most districts after 2008.
Data from districts surveyed during the first and second follow up surveys (Fig 4A) showed an
increase in MF prevalence in 12 districts (Biankouma, Bondoukou, Bouake´, Bouna, Dabakala,
Daloa, Daoukro, Ferke´sse´dougou, Korhogo, Ouangolo, Se´gue´la, Touba). On the other hand,
MF prevalence and CMFL decreased between the two follow up surveys in 13 endemic districts
(Abengourou, Adzope´, Ale´pe´, Dimbokro, Ferke´sse´dougou, Issia, Man, Mankono, Odie´nne´,
Soubre´, Tengre´la, Tiassale´, Zuenoula) despite gaps in MDA in nine of them. Only four of these
13 districts were continuously treated since 2008 (Abengourou, Dimbokro, Mankono, Odi-
e´nne´). In Bouake´ and Korhogo districts, the MF rate was <1% in the first follow up survey car-
ried out between 1992 and 2001 but> 1% after 2002. According to World Health
Organisation-APOC guidelines [9], this increase meets the criterion for a recrudescence.
Discussion
OCP was set up in 1974 with the objective to control the disease as a public health problem
rather than to achieve elimination of the infection and transmission. During OCP period, con-
trol of onchocerciasis was planned to be achieved by weekly aerial application of insecticide
(temephos) to the riverine breeding sites of the vector Simulium damnosum s.l. The original
OCP area included most of West African countries such as Burkina Faso, Mali, Coˆte d’Ivoire,
Ghana, Togo, Benin and Niger. In Coˆte d’Ivoire, OCP success in Coˆte d’Ivoire was illustrated
by the significant drop recorded after more than 10 years of aerial insecticide spraying. Oncho-
cerciasis MF prevalence dropped significantly from 43.1% (95%CI 42.6–44.3) to 13.9% (95%CI
12.8–15.1) as well as the CMFL [from 9.24 (range 0.05–44.8) MF/snip to 0.44 (range 0–4.64)
MF/snip].
After OCP interventions, prevalence of onchocerciasis dropped steadily but was less than
5% in only one out of 8 districts surveyed after the cessation of vector control by 1991. Oncho-
cerciasis MF prevalence was above 10% in 6 out of 8 districts. Vector control contributed to
reduce significantly the prevalence of onchocerciasis in most OCP countries. However, preva-
lence of infection in the human population never dropped to zero despite 10 years of interven-
tion, and they were not below the level at which it may represent the transmission breakpoint
in 7 out of 8 districts [10]. A recent epidemiological modelling study concluded that the risk of
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recrudescence depended on the pre-control endemicity level as an indicator of the local poten-
tial of transmission [15]. Though in some of our districts the pre-control endemicity levels
were high, the country has now a chance for elimination of this disease knowing that since
June 2017 MDA is implementing annually in the entire country [16]. This was not observed
probably because most of the study villages may have been subject to vector reinvasion and the
programme experienced short periods of suspension of aerial larvicides application. Further-
more, suspension of larviciding during some periods may have contributed to increase pro-
ductivity of blackfly breeding sites which may have contributed to maintain vector densities at
a level that could sustain transmission of O. volvulus as previously demonstrated [17].
After years of aerial insecticide spraying, control of onchocerciasis was complemented by
ivermectin mass treatment of the at-risk population after Merck & Co. Inc. agreed to donate
ivermectin in 1987 [18]. This new strategy led by APOC was based on the implementation of
CDTi which was successfully conducted until 2007. With APOC creation in 1995, a strong
partnership was set up with onchocerciasis endemic countries which has helped these coun-
tries to successfully extend CDTi coverage from 1.5 million in 1997 to over 112 million people
in 2014, reaching over 180 000 communities in Africa [19]. This enormous achievement in
control of onchocerciasis in Africa was materialized by growing evidence that ivermectin
alone could be used to eliminate infection and reduce transmission to levels at which treatment
with ivermectin could be safely stopped after more than 10 rounds of CDTi implementation.
In Coˆte d’Ivoire, after at least five rounds of annual ivermectin distribution, the second and
the third epidemiological evaluations in 36 endemic districts, revealed significant decreases in
onchocerciasis MF prevalence and CMFL.
Indeed, before ivermectin distribution started in 1992, the overall community prevalence of
O. volvulus MF in the skin was 41.6% (range 3.9% to 85.0%). After 8–10 years of treatment, the
prevalence had fallen to less than 1% in 2 districts and remained above 5% in 15 endemic dis-
tricts. In view of previous experiences with onchocerciasis elimination in West Africa, these
reductions are significant but lower than those observed in Senegal and Mali where the preva-
lence of MF had fallen below 1% in most of the villages after implementation of 10 rounds of
CDTi [20]. However, the reduction observed in some endemic districts of Coˆte d’Ivoire may
be considered to be important, because it occurred after implementation of a minimum of 5
rounds of CDTi. Indeed, repeated and continuous annual distribution of ivermectin helped to
prevent the onset of new cases and reduce transmission [21] with the goal of reducing oncho-
cerciasis prevalence to a level that cannot sustain transmission. Similar studies aimed to deter-
mine onchocerciasis MF prevalence and CMFL have been reported in Sierra Leone and
Cameroon after repeated annual treatment with ivermectin [22,23]. Our findings are similar
to those recently reported in Sierra Leone where skin MF prevalence were still between 10 and
30% after implementation of 5 continuous MDA rounds with ivermectin [24].
This paper has emphasized that efforts to control onchocerciasis in Coˆte d’Ivoire have
made a significant impact despite various challenges. Although civil conflict has hampered
onchocerciasis control programs in Coˆte d’Ivoire and neighbouring countries, we are optimis-
tic about the future; improved political stability should facilitate regular distribution of iver-
mectin that will slowly reduce infection prevalence and intensities and shrink the map.
Indeed, studies conducted recently in several meso and lower-hyper-endemic settings in Mali,
Senegal [25] and Nigeria [26] have shown that repeated distribution of ivermectin alone can
interrupt O. volvulus transmission, and these results provide a proof of principal for Coˆte
d’Ivoire’s program.
Data from Coˆte d’Ivoire showed that disruption in CDTi related to the civil war had an
effect on onchocerciasis rates or CMFL. The overall MF prevalence and the CMFL increased
from the second to the third evaluation in 10 endemic districts. This may be firstly due to the
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absence of MDA implementation in 2003, 2004 and 2007 in endemic districts from Western,
Northern and Central regions occupied by rebels, and secondly, from 1992 to 2014, only 10
out of 36 districts surveyed for onchocerciasis were continuously treated with ivermectin
meaning that MDA was not carried out continuously in the other 26 districts. Finally, before
2015, in Coˆte d’Ivoire ivermectin distribution never reached villages with more than 2,000
inhabitants even if they are close to basins of rivers hosting breeding sites of black flies. These
weaknesses may have contributed to the increase of MF prevalence and CMFL in these 10
districts.
One of the great achievements of Coˆte d’Ivoire Onchocerciasis control programme is that
MDA coverage was often above the target required for control and for elimination in regions
controlled by the elected government where MDA implementation was not suspended. The
challenge now will be to deliver ivermectin with high compliance to all endemic areas in the
country because it was done previously at small scale. As MDA will now be carried out at dis-
trict level in all districts co-endemic for LF and onchocerciasis, the country may be faced to
challenges such as hard to reach areas, migratory populations, local health systems deficiencies
(e.g. at the level of CDD). Our findings showed that reaching the effective coverage threshold
for elimination (>65%) is key for accelerating elimination of preventive chemotherapy dis-
eases such as LF and onchocerciasis. Our results corroborated results of recent study carried
out in Cameroon where despite more than 15 years of mass treatment, microfilaridermia prev-
alence did not decrease [27]. In this study the persistence of the transmission of O. volvulus
was favoured by the low adherence of targeted communities to treatment because only 40 to
54% of people from the study areas confirmed having taken five treatments during the last five
years [27]. Thus, as demonstrated recently in Mali and Nigeria [25,26], if CDTi continues to
be well implemented in Coˆte d’Ivoire, this may lead to interruption of onchocerciasis trans-
mission the coming years. A recent APOC review concluded that that effective ivermectin dis-
tribution can lead to elimination of onchocerciasis if CDTi is properly implemented as
demonstrated in many countries [28]. Coˆte d’Ivoire would like to contribute its own success
stories to this narrative, but this will take time, effort, and sustained support from within the
country and from international partners.
Despite important findings presented previously, our study has several limitations. The
data presented are government surveillance data and were not collected as part of a systematic
study. For example, epidemiological assessments were not carried out in the same years in all
districts. Not all endemic areas received ivermectin, and surveys did not sample localities with
populations greater than 2,000. Despite these limitations, the surveillance data are valuable,
because they demonstrate the impact of interventions during different periods over the past 40
years in Coˆte d’Ivoire. The elimination effort will require more and better data. Current WHO
elimination guidelines [29] recommend starting with a situation analysis with updated surveys
to confirm the current status of each district. Districts with MF rates <1% should have ento-
mological evaluation in order to detect residual transmission during at least one transmission
season before confirming interruption of transmission [29].
In conclusion, despite the limitations and weaknesses of the available data, this large body
of data collected over many years documents very significant impact of interventions (vector
control and CDTi) by the national onchocerciasis control programme despite challenges. OCP
and APOC support were essential contributors to this success. However, our study also
showed clearly that Coˆte d’Ivoire has still a major onchocerciasis problem due mainly to the
civil war and instability of the country, lack of support from international donors resulting in
the irregularity of MDA implementation for onchocerciasis. Now that the country has a
unique programme for all the five preventive chemotherapy diseases and has started since
2015 MDA national coverage for LF and onchocerciasis, we are confident that great progress
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will be made to move from control to elimination of the disease. However, where onchocercia-
sis transmission will persist despite successful MDA implementation, the country will need to
carry out alternative strategies such as twice annual distribution of ivermectin, doxycycline test
and treat and/or ground larviciding.
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